Novavax plans for second round of layoffs, cost cuts as weak vaccine uptake pummels manufacturers
Published
Six months after announcing a first wave of cost cuts, Novavax is instituting another round, looking to shave off a further $300 million in spending with more layoffs on the way. The drug developer, which is still sprinting to catch up to Pfizer and Moderna in the COVID-19 vaccine race, announced…
#pfizer #fierce #sga #cfojimkelly #johnjacobs #jacobs #moderna